Liquid Biopsies Could Guide NSCLC Treatment

A liquid biopsy may be able to predict the efficacy of EGFR-targeted tyrosine kinase inhibitors in patients with non –small cell lung cancer.

Source: CancerNetwork - October 21, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news